UK-based consumer health player Venture Life Group has expanded its product portfolio and broadened its reach in Europe with the acquisition of Pharma Source BV for an initial €5.23m ($5.81m), plus a deferred contingent consideration of up to €1.27m.
Netherlands-based development and distribution firm Pharma Source markets a range of medical devices across many therapeutic areas including fungal nail infections, wart removal and women's health. It owns various medical...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?